CMS Drops QRS Restriction From Defibrillator Policy, Requires Registry

Guidant will lobby CMS to reconsider the COMPANION CRT-D trial data before finalizing a new implantable cardioverter defibrillator coverage policy

More from Archive

More from Medtech Insight